申请人:Rigel Pharmaceuticals, Inc.
公开号:US20160257690A1
公开(公告)日:2016-09-08
Disclosed are imidazole and thiazole compounds, as well as pharmaceutical compositions and methods of use thereof. One embodiment is a compound having the structure
and pharmaceutically acceptable salts, prodrugs and N-oxides thereof (and solvates and hydrates thereof), wherein X, A, Z, R
1
and R′ are as described herein. In certain embodiments, a compound disclosed herein inhibits TGF-β, and can be used to treat disease by blocking TGF-β signaling.
本文披露了咪唑和噻唑化合物,以及其药物组合物和使用方法。一个实施例是具有以下结构的化合物
及其药用可接受盐、前药和N-氧化物(以及其溶剂和水合物),其中X、A、Z、R1和R'如本文所述。在某些实施例中,本文披露的化合物抑制TGF-β,并可用于通过阻断TGF-β信号传导来治疗疾病。